Premier Health Announces Additions to the Leadership Team
VANCOUVER, British Columbia, Jan. 25, 2019 (GLOBE NEWSWIRE) — Premier Health Group (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” […]
BrainStorm Cell Therapeutics to Present at the 2019 NobleCon15 Annual Investor Conference in Fort Lauderdale, Florida
NEW YORK, Jan. 25, 2019 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous […]
Helius Medical Technologies, Inc. Provides Update on FDA’s Review of its Request for De Novo Classification and 510(k) Clearance of the PoNS™ Device
NEWTOWN, Pa., Jan. 25, 2019 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]
Liberty Home Equity Solutions Named One of the Best Mortgage Companies to Work for by National Mortgage News
Only exclusive lender of reverse mortgages named to the 2019 list WEST PALM BEACH, Fla., Jan. 25, 2019 (GLOBE NEWSWIRE) […]
ENSERVCO Updates Investors on 2018 Fourth Quarter and Full Year Financial Expectations
DENVER, Jan. 25, 2019 (GLOBE NEWSWIRE) — ENSERVCO Corporation (NYSE American: ENSV), a diversified national provider of specialized well-site services […]
Allegiance Bancshares, Inc. Reports Record Year-End 2018 Results
Total assets of $4.66 billion after the completion of the acquisition of Post Oak Bancshares, Inc. on October 1, 2018 Record […]
Aleafia Health Study Indicates 45% of Patients End Benzodiazepine Use Following Medical Cannabis Treatment
First of its Kind Study Published in Peer-Reviewed Journal, “Cannabis and Cannabinoid Research” Authors Leveraged Aleafia’s 10 Million Point Medical […]
FLOWR EXPANDS R&D TEAM WITH HIRING OF NORTH AMERICA’S FIRST CANNABIS CULTIVATION PhD
Deron Caplan Adds Depth to Leading R&D Capability that Includes Exclusive Alliance with a Scotts Miracle-Gro Division Markham, Ontario, Jan. […]
Datametrex Promotes Marshall Gunter From CTO to CEO of Nexalogy
TORONTO, Jan. 25, 2019 (GLOBE NEWSWIRE) — Datametrex AI Limited (the “Company” or “Datametrex”) (TSXV: DM, FSE: D4G) is pleased […]
Interpace Diagnostics Announces Pricing of $7.0 Million Public Offering of Common Stock
PARSIPPANY, N.J., Jan. 25, 2019 (GLOBE NEWSWIRE) — Interpace Diagnostics Group, Inc. (Nasdaq: IDXG) (“Interpace” or the “Company”) today announced […]
